1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice


Discussion in 'Savient' started by Anonymous, Oct 24, 2013 at 11:18 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Well looks like the offers are in and heads will roll at SVNT. Many of us LUCKY ones are going to Genzyme and not a day to soon. Got my offer this week and going to tell my boss and P.Patel to go fly a kite.

    For the rest of you left, God speed and good luck!